OrthoPediatrics Corp. is listed today as OrthoPediatrics Corp.: market value, financials and filings are on its company page.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2014 | $39 M | No. 2 | $10 to $50 million | equity | SEC | |
| Jan 2008 | $13 M | No. 1 | $10 to $50 million | equity, debt | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company OrthoPediatrics Corp., its revenue in fiscal 2025 came from these product and service lines: Trauma and deformity $166.30 million (70%), Scoliosis $66.05 million (28%), Sports medicine/other $4 million (2%).
Annual report (SEC XBRL) · Dec 2025
OrthoPediatrics Corp. chose not to state its revenue in its newest notice of a funding round (Jun 2014).
SEC Form D · Jun 2014
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jun 2014
Products and services#
No products or services of OrthoPediatrics Corp. are on record.
Investors#
3 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Bernie B. Berry III | Person | not stated | not stated | Held Series B preferred stock, director (Form 3, 2017) | SEC Form 3 |
| Mark C. Throdahl | Person | not stated | not stated | Held Series B preferred stock, director (Form 3, 2017) | SEC Form 3 |
| Squadron Capital LLC | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2017) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 202 investors.
Largest shareholders today
Institutions holding OrthoPediatrics Corp. shares, as of Sep 30, 2026.
- Brown Advisory Inc$36 M6.15%
- BlackRock, Inc.$29 M4.94%
- AIGH Capital Management LLC$26 M4.49%
- Braidwell LP$25 M4.21%
- Granahan Investment Management, LLC$19 M3.28%
- Vanguard Capital Management LLC$17 M2.88%
- Wellington Management Group LLP$17 M2.85%
- Soleus Capital Management, L.P.$16 M2.72%
- Morgan Stanley$13 M2.31%
- Dimensional Fund Advisors LP$11 M1.91%
- Wasatch Advisors LP$10 M1.80%
- State Street Corp$10 M1.70%
- Geode Capital Management, LLC$10 M1.66%
- Goldman Sachs Group Inc$8 M1.36%
- Roubaix Capital, LLC$8 M1.30%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Daniel J Gerritzen | Executive officer | Jun 2014 |
| David Bailey | Executive officer | Jun 2014 |
| Greg Odle | Executive officer | Jun 2014 |
| Mark C Throdahl | Executive officer | Jun 2014 |
| Steve C Miller | Executive officer | Jun 2014 |
| Bob von Seggern | Executive officer | Jul 2009 |
| Gary Barnett | Executive officer | Jul 2009 |
| Greg Downey | Executive officer | Jul 2009 |
| Isaac Mensah | Executive officer | Jul 2009 |
| Jeff Minaudo | Executive officer | Jul 2009 |
| Mark Scrafton | Executive officer | Jul 2009 |
| Nick A Deeter | Executive officer | Jul 2009 |
| Terry Schlotterback | Executive officer | Jul 2009 |
| Thomas Slagle | Executive officer | Jul 2009 |
| Bernie B Berry III | Director | Jun 2014 |
| Bryan C Hughes | Director | Jun 2014 |
| David Bailey | Director | Jun 2014 |
| David C Pelizzon | Director | Jun 2014 |
| Greg Odle | Director | Jun 2014 |
| Kevin C Unger | Director | Jun 2014 |
| Mark C Throdahl | Director | Jun 2014 |
| Oscar Moralez | Director | Jun 2014 |
| Peter C Munson | Director | Jun 2014 |
| Terry Schlotterback | Director | Jun 2014 |
| Gary Barnett | Director | Jul 2009 |
| Greg Downey | Director | Jul 2009 |
| Isaac Mensah | Director | Jul 2009 |
| Nick A Deeter | Director | Jul 2009 |
Went public since 2017. Its SEC number is that of a company listed on a stock exchange.